Effects of Provider Commitments to Choose Wisely
Provider, Patient, and Health System Effects of Provider Commitments to Choose Wisely
1 other identifier
interventional
489
1 country
9
Brief Summary
Clinicians' decisions to order potentially unnecessary services -- such as those targeted in the Choosing Wisely® campaign -- are often affected by their high-pressure practice environments, which can make it hard to consistently avoid ordering low-value care. The field of behavioral economics offers a promising and highly scalable approach to decreasing use of low-value services: asking clinicians to commit to avoid ordering such services and providing them and their patients with resources to support adherence to this commitment. This project will evaluate the effects of such an intervention across 2 large health systems, Michigan Medicine and IHA, through a mixed-methods, stepped wedge cluster randomized trial. In each of the study clinics, clinicians will be invited to commit to following a set of targeted Choosing Wisely® recommendations. Clinicians who make such a commitment, and their patients, will receive access to key resources to support adherence to this commitment. To measure the effects of the intervention, automated clinical data and medical record data before and after the intervention will be examined. Surveys and semi-structured interviews of both clinicians and patients will also be conducted to determine the effects of the intervention on their decision-making and experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2018
CompletedFirst Posted
Study publicly available on registry
January 26, 2018
CompletedStudy Start
First participant enrolled
January 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2019
CompletedMarch 7, 2019
March 1, 2019
9 months
January 19, 2018
March 5, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in the proportion of intervention and control period visits with an applicable low-value treatment or test as specified by each respective Choosing Wisely® recommendation
The applicable low-value treatments or tests specified by the respective Choosing Wisely® recommendations are use of hypoglycemic medications for patients 65 years or older with diabetes and tight glycemic control, PSA testing among men 75 years or older with no history of prostate cancer, and use of benzodiazepine or sedative-hypnotic medications for patients with insomnia or anxiety who are 65 years or older.
10 months
Secondary Outcomes (4)
Patient trust in primary care provider
Within 1 week of primary care visit
Patient rating of provider
Within 1 week of primary care visit
Frequency of patient-provider conversations about the applicable low-value treatments or tests
Within 1 week of primary care visit
Composite difference in the proportion of intervention and control period visits with an applicable low-value treatment or test as specified by each respective Choosing Wisely® recommendation
10 months
Study Arms (8)
Commitment invitation at time 1
EXPERIMENTALIn the stepped wedge cluster randomized design, the first clinic will remain in the control period (no intervention) for 1 month, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 8 months.
Commitment invitation at time 2
EXPERIMENTALIn the stepped wedge cluster randomized design, the second clinic will remain in the control period (no intervention) for 2 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 7 months.
Commitment invitation at time 3
EXPERIMENTALIn the stepped wedge cluster randomized design, the third clinic will remain in the control period (no intervention) for 3 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 6 months.
Commitment invitation at time 4
EXPERIMENTALIn the stepped wedge cluster randomized design, the fourth clinic will remain in the control period (no intervention) for 4 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 5 months.
Commitment invitation at time 5
EXPERIMENTALIn the stepped wedge cluster randomized design, the fifth clinic will remain in the control period (no intervention) for 5 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 4 months.
Commitment invitation at time 6
EXPERIMENTALIn the stepped wedge cluster randomized design, the sixth clinic will remain in the control period (no intervention) for 6 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 3 months.
Commitment invitation at time 7
EXPERIMENTALIn the stepped wedge cluster randomized design, the seventh clinic will remain in the control period (no intervention) for 7 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 2 months.
Commitment invitation at time 8
EXPERIMENTALIn the stepped wedge cluster randomized design, the eighth clinic will remain in the control period (no intervention) for 8 months, followed by a 1 month transition period (where data will not be collected), before crossing over to the intervention period for 1 month.
Interventions
Clinicians will be invited to commit to follow 3 Choosing Wisely® recommendations. Those that choose to commit will sign a written document, appear on in-clinic posters along with their colleagues who have committed to the recommendations, have access to point-of-care Choosing Wisely® patient education handouts, and receive weekly emails with decision support resources.
During the intervention period, the letter and study information sheet that eligible patients will receive in advance of a scheduled appointment with a participating clinician will also be accompanied by a patient education handout from Consumer Reports that is publicly available and may be relevant to their health and health care. Specifically, patients with type 2 diabetes who are 65 and older will receive a handout about diabetes overtreatment, patients with insomnia or anxiety who are 65 and older will receive a handout about overuse of benzodiazepines and sedative-hypnotics, and male patients who are 75 and older with no history of prostate cancer will receive a handout about overuse of PSA tests to screen for prostate cancer.
Eligibility Criteria
You may qualify if:
- Clinician participants will be drawn from the pool of physicians, nurse practitioners, and physician assistants staffing the 8 primary care clinics.
- Patients of all 8 study clinics must meet criteria for one of the three Choosing Wisely® recommendations to be eligible to participate:
- and older with type 2 diabetes
- and older with insomnia and/or anxiety
- male, 75 and older with no history of prostate cancer.
You may not qualify if:
- Patients who have cognitive impairment and/or a serious psychiatric diagnosis will not be eligible to participate in the surveys or interviews.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Donaghue Medical Research Foundationcollaborator
- Integrated Health Associatescollaborator
Study Sites (9)
IHA Family & Internal Medicine - West Arbor
Ann Arbor, Michigan, 48103, United States
IHA Internal Medicine - Domino's Farms
Ann Arbor, Michigan, 48105, United States
Michigan Medicine Briarwood Medical Group
Ann Arbor, Michigan, 48108, United States
Michigan Medicine East Ann Arbor Health and Geriatrics Center
Ann Arbor, Michigan, 48109, United States
University of Michigan Medical School
Ann Arbor, Michigan, 48109, United States
Michigan Medicine Brighton Health Center
Brighton, Michigan, 48116, United States
IHA Family & Internal Medicine - Cherry Hill
Canton, Michigan, 48187, United States
Michigan Medicine Canton Health Center
Canton, Michigan, 48187, United States
IHA Internal Medicine - Towsley
Ypsilanti, Michigan, 48197, United States
Related Publications (1)
Kullgren JT, Kim HM, Slowey M, Colbert J, Soyster B, Winston SA, Ryan K, Forman JH, Riba M, Krupka E, Kerr EA. Using Behavioral Economics to Reduce Low-Value Care Among Older Adults: A Cluster Randomized Clinical Trial. JAMA Intern Med. 2024 Mar 1;184(3):281-290. doi: 10.1001/jamainternmed.2023.7703.
PMID: 38285565DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey T. Kullgren, MS, MD, MPH
University of Michigan
- PRINCIPAL INVESTIGATOR
Eve Kerr, MD, MPH
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Internal Medicine
Study Record Dates
First Submitted
January 19, 2018
First Posted
January 26, 2018
Study Start
January 26, 2018
Primary Completion
November 1, 2018
Study Completion
February 28, 2019
Last Updated
March 7, 2019
Record last verified: 2019-03